Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-16 20:30 | 2026-09-15 | CORT | CORCEPT THERAPEUTICS INC | WILSON JAMES N | Director | SELL | $110.69 | 10,000 | $1,106,940 | 1,064,543 |
| 2026-09-16 20:20 | 2026-09-15 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Director, Officer | SELL | $71.00 | 5,400 | $383,400 | 339,089 |
| 2026-09-17 01:06 | 2026-09-14 | PBYI | PUMA BIOTECHNOLOGY, INC. | Cesano Alessandra | Director | OPT+S | $9.12 | 62,150 | $566,994 | 56,700 |
| 2026-09-17 01:13 | 2026-09-14 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Director | SELL | $9.10 | 5,000 | $45,500 | 54,750 |
| 2026-09-16 22:58 | 2026-09-14 | INM | InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC | 10% owner | BUY | $1.30 | 91,101 | $118,076 | 892,101 |
| 2026-09-16 20:35 | 2026-09-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $501.59 | 9,500 | $4,765,119 | 324,443 |
| 2026-09-16 18:00 | 2026-09-15 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Director, Officer | SELL | $4.82 | 25,000 | $120,488 | 652,317 |
| 2026-09-16 18:07 | 2026-09-14 | PHVS | Pharvaris N.V. | Souverijns Wim | Officer | OPT+S | $39.23 | 26,090 | $1,023,576 | 39,021 |
| 2026-09-16 17:19 | 2026-09-16 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | CTT PHARMACEUTICAL HOLDINGS, INC. | Director, Officer | BUY | $0.05 | 10,900 | $523 | 9,414,456 |
| 2026-09-15 20:10 | 2026-09-14 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | Officer | OPT+S | $98.37 | 9,943 | $978,093 | 44,745 |
| 2026-09-15 20:12 | 2026-09-11 | ISCO | International Stem Cell CORP | MAIER PAUL V | Director | SELL | $0.32 | 32,802 | $10,497 | 0 |
| 2026-09-15 20:15 | 2026-09-11 | KRRO | Korro Bio, Inc. | FORMELA JEAN FRANCOIS | Director | SELL | $14.09 | 48,690 | $686,178 | 132,650 |
| 2026-09-16 01:30 | 2026-09-11 | TENX | TENAX THERAPEUTICS, INC. | STAAB THOMAS R II | Officer | BUY | $1.94 | 5,675 | $10,981 | 15,675 |
| 2026-09-16 01:38 | 2026-09-11 | TENX | TENAX THERAPEUTICS, INC. | Giordano Christopher Thomas | Director, Officer | BUY | $1.85 | 10,850 | $20,088 | 22,174 |
| 2026-09-16 01:15 | 2026-09-11 | PVLA | PALVELLA THERAPEUTICS, INC. | JENKINS GEORGE M | Director | SELL | $151.53 | 27,500 | $4,167,147 | 160,116 |
| 2026-09-16 01:12 | 2026-09-14 | TAK | TAKEDA PHARMACEUTICAL CO LTD | Duprey Lauren Rusckowski | Officer | SELL | $18.54 | 34,535 | $640,279 | 191,522 |
| 2026-09-16 00:45 | 2026-09-11 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | CHEN THOMAS C | Director, Officer, 10% owner | BUY | $3.70 | 10,798 | $40,000 | 24,503 |
| 2026-09-16 00:47 | 2026-09-14 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | Heshmatpour Amir F | Director, Officer, 10% owner | BUY | $3.50 | 50,000 | $174,795 | 3,183,000 |
| 2026-09-16 00:44 | 2026-09-14 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | GARNETT KEITHLY | Officer | BUY | $3.89 | 257 | $1,001 | 242,357 |
| 2026-09-16 00:27 | 2026-09-11 | RCKT | ROCKET PHARMACEUTICALS, INC. | Wilson Martin | Officer | SELL | $3.40 | 75,364 | $256,464 | 598,489 |
| 2026-09-15 23:15 | 2026-09-15 | ORKA | Oruka Therapeutics, Inc. | Klein Lawrence Otto | Director, Officer | SELL | $95.71 | 2,452 | $234,681 | 923,128 |
| 2026-09-15 23:17 | 2026-09-11 | ORKA | Oruka Therapeutics, Inc. | Agarwal Arjun | Officer | OPT+S | $92.43 | 10,019 | $926,010 | 14,752 |
| 2026-09-15 23:18 | 2026-09-15 | ORKA | Oruka Therapeutics, Inc. | Goncalves Joana | Officer | OPT+S | $92.38 | 7,947 | $734,145 | 31,771 |
| 2026-09-15 22:57 | 2026-09-15 | RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | Officer | SELL | $13.57 | 1,283 | $17,410 | 67,863 |
| 2026-09-15 23:11 | 2026-09-15 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | Officer | SELL | $95.71 | 906 | $86,713 | 235,478 |
| 2026-09-15 23:14 | 2026-09-15 | ORKA | Oruka Therapeutics, Inc. | Quinlan Paul T | Officer | SELL | $95.71 | 1,039 | $99,443 | 29,995 |
| 2026-09-15 21:20 | 2026-09-14 | CYTK | CYTOKINETICS INC | Blum Robert I | Director, Officer | OPT+S | $69.62 | 105,426 | $7,340,011 | 0 |
| 2026-09-15 21:23 | 2026-09-15 | CYTK | CYTOKINETICS INC | Landry Robert E | Director | SELL | $72.13 | 1,000 | $72,130 | 8,184 |
| 2026-09-15 20:59 | 2026-09-14 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Ben Yong | Director | SELL | $7.84 | 2,000 | $15,683 | 9,383 |
| 2026-09-15 20:30 | 2026-09-14 | NAMS | NewAmsterdam Pharma Co N.V. | Davidson Michael H. | Director, Officer | BUY | $22.65 | 10,000 | $226,500 | 792,923 |
| 2026-09-15 20:30 | 2026-09-11 | LQDA | Liquidia Corp | SINGH RAMAN | Director | OPT+S | $67.43 | 17,492 | $1,179,452 | 44,637 |
| 2026-09-15 20:30 | 2026-09-11 | IRON | Disc Medicine, Inc. | Bitterman Kevin | Director | OPT+S | $70.11 | 27,136 | $1,902,505 | 0 |
| 2026-09-15 20:30 | 2026-09-11 | IMNM | Immunome Inc. | Higgins Jack | Officer | OPT+S | $25.32 | 13,200 | $334,224 | 65,050 |
| 2026-09-15 20:33 | 2026-09-14 | UTHR | UNITED THERAPEUTICS Corp | Mesa Nilda | Director | OPT+S | $505.87 | 228 | $115,338 | 5,580 |
| 2026-09-15 20:34 | 2026-09-14 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $504.12 | 9,500 | $4,789,152 | 324,443 |
| 2026-09-15 18:30 | 2026-09-11 | PHVS | Pharvaris N.V. | Lu Peng | Officer | OPT+S | $40.13 | 15,000 | $601,947 | 65,179 |
| 2026-09-15 18:15 | 2026-09-14 | PHVS | Pharvaris N.V. | Modig Berndt | Director, Officer | SELL | $39.40 | 2,291 | $90,276 | 128,334 |
| 2026-09-15 10:33 | 2026-09-14 | MAIA | MAIA Biotechnology, Inc. | Vitoc Vlad | Director, Officer, 10% owner | BUY | $1.37 | 73,000 | $100,010 | 1,049,121 |
| 2026-09-14 20:59 | 2026-09-10 | LGND | LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Director | SELL | $285.00 | 1,200 | $342,000 | 3,897 |
| 2026-09-14 20:05 | 2026-09-11 | KRRO | Korro Bio, Inc. | Dolan Oliver | Officer | SELL | $13.72 | 5 | $69 | 16,241 |
| 2026-09-14 20:00 | 2026-09-10 | AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Officer | SELL | $32.46 | 9,536 | $309,506 | 190,838 |
| 2026-09-14 20:00 | 2026-09-10 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Director, Officer | SELL | $32.19 | 30,464 | $980,505 | 3,613,123 |
| 2026-09-14 20:00 | 2026-09-10 | AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Director, Officer | SELL | $32.18 | 30,464 | $980,264 | 3,613,056 |
| 2026-09-14 20:00 | 2026-09-10 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Officer | SELL | $32.40 | 10,028 | $324,868 | 278,064 |
| 2026-09-14 20:00 | 2026-09-10 | AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Officer | SELL | $32.36 | 10,810 | $349,820 | 233,625 |
| 2026-09-15 00:56 | 2026-09-14 | ANIP | ANI PHARMACEUTICALS INC | Cook Meredith | Officer | SELL | $70.79 | 500 | $35,395 | 73,924 |
| 2026-09-15 00:57 | 2026-09-11 | ANIP | ANI PHARMACEUTICALS INC | Thoma Jeanne | Director | SELL | $71.53 | 1,000 | $71,530 | 26,762 |
| 2026-09-14 23:20 | 2026-09-07 | TLX | Telix Pharmaceuticals Ltd | Smith Darren Charlton | Officer | BUY | $9.66 | 2,071 | $19,998 | 13,992 |
| 2026-09-14 23:37 | 2026-09-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Director, Officer | OPT+S | $102.67 | 50,000 | $5,133,440 | 239,258 |
| 2026-09-15 00:00 | 2026-09-10 | MNKD | MANNKIND CORP | Binder Steven B. | Director | SELL | $3.81 | 33,558 | $127,856 | 752,309 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.